Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2019

Open Access 01-12-2019 | Systemic Lupus Erythematosus | Case report

Acute myocardial infarction in a patient positive for lupus anticoagulant: a case report

Authors: Kota Murai, Kenji Sakata, Tadatsugu Gamou, Yoji Nagata, Hayato Tada, Masaya Shimojima, Hirofumi Okada, Kenshi Hayashi, Masa-aki Kawashiri

Published in: BMC Cardiovascular Disorders | Issue 1/2019

Login to get access

Abstract

Background

Autoimmune diseases, such as systemic lupus erythematosus (SLE), are associated with thrombosis and atherosclerosis. Presence of lupus anticoagulant is an independent risk factor for atherosclerotic diseases.

Case presentation

A 56-year-old man with past history of hypertension, and cerebral infarction was admitted to our hospital owing to acute chest pain. He was diagnosed with acute myocardial infarction based on his symptoms and electrocardiogram results, which demonstrated ST elevation in the precordial leads. Coronary angiography images revealed total occlusion at the proximal site of the left anterior descending artery. A drug-eluting stent was deployed, which successfully recovered coronary blood flow. The patient had fever of unknown cause when he was 30 years old; on admission, he presented with a low-grade fever and reddish exanthema affecting both cheeks. Based on his physical signs as well as elevated antinuclear antibodies (anti-double-stranded DNA), decreased lymphocytes, and a positive direct Coombs test, he was diagnosed with SLE. Owing to a positive lupus anticoagulant test, he was also suspected to have antiphospholipid syndrome (APS). Triple antithrombotic therapy, including dual antiplatelet therapy with aspirin and clopidogrel during coronary stenting and single anticoagulation therapy with warfarin, was initiated.

Conclusions

Careful diagnosis of autoimmune diseases should be performed in patients with thrombosis and atherosclerosis. Moreover, risk factors for coronary artery disease should be strictly controlled in patients with APS.
Literature
1.
go back to reference Hughes GR. The antiphospholipid syndrome: ten years on. Lancet. 1993;342:341–4.CrossRef Hughes GR. The antiphospholipid syndrome: ten years on. Lancet. 1993;342:341–4.CrossRef
2.
go back to reference Mineo C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep. 2013;15:324.CrossRef Mineo C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep. 2013;15:324.CrossRef
3.
go back to reference Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6:379–86.CrossRef Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6:379–86.CrossRef
4.
go back to reference Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017;69:2317–30.CrossRef Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017;69:2317–30.CrossRef
5.
go back to reference Ando T, Adegbala O, Akintoye E, Ashraf S, Briasoulis A, Takagi H, et al. Acute myocardial infarction outcomes in systemic lupus erythematosus (from the nationwide inpatient sample). Am J Cardiol. 2019;123:227–32.CrossRef Ando T, Adegbala O, Akintoye E, Ashraf S, Briasoulis A, Takagi H, et al. Acute myocardial infarction outcomes in systemic lupus erythematosus (from the nationwide inpatient sample). Am J Cardiol. 2019;123:227–32.CrossRef
6.
go back to reference Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017;76:10–20.CrossRef Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017;76:10–20.CrossRef
7.
go back to reference González-Pacheco H, Eid-Lidt G, Piña-Reyna Y, Amezcua-Guerra LM, Aldana-Sepúlveda N, Martínez-Sánchez C. Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome. Am J Emerg Med. 2014;32:197.e3–5.CrossRef González-Pacheco H, Eid-Lidt G, Piña-Reyna Y, Amezcua-Guerra LM, Aldana-Sepúlveda N, Martínez-Sánchez C. Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome. Am J Emerg Med. 2014;32:197.e3–5.CrossRef
8.
go back to reference Cavallari I, Patti G. Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol. 2018;121:718–24.CrossRef Cavallari I, Patti G. Meta-analysis comparing the safety and efficacy of dual versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol. 2018;121:718–24.CrossRef
9.
go back to reference Bazzan M, Vaccarino A, Stella S, Bertero MT, Carignola R, Montaruli B, et al. Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont cohort. Autoimmun Rev. 2013;12:826–31.CrossRef Bazzan M, Vaccarino A, Stella S, Bertero MT, Carignola R, Montaruli B, et al. Thrombotic recurrences and bleeding events in APS vascular patients: a review from the literature and a comparison with the APS Piedmont cohort. Autoimmun Rev. 2013;12:826–31.CrossRef
Metadata
Title
Acute myocardial infarction in a patient positive for lupus anticoagulant: a case report
Authors
Kota Murai
Kenji Sakata
Tadatsugu Gamou
Yoji Nagata
Hayato Tada
Masaya Shimojima
Hirofumi Okada
Kenshi Hayashi
Masa-aki Kawashiri
Publication date
01-12-2019

Other articles of this Issue 1/2019

BMC Cardiovascular Disorders 1/2019 Go to the issue